316 related articles for article (PubMed ID: 21487108)
1. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
[TBL] [Abstract][Full Text] [Related]
2. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
[TBL] [Abstract][Full Text] [Related]
3. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Yarchoan R
Curr Opin Oncol; 2012 Sep; 24(5):495-505. PubMed ID: 22729151
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
[No Abstract] [Full Text] [Related]
7. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
[TBL] [Abstract][Full Text] [Related]
8. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
[TBL] [Abstract][Full Text] [Related]
9. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R
J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
Ramaswami R; Lurain K; Polizzotto MN; Ekwede I; Waldon K; Steinberg SM; Mangusan R; Widell A; Rupert A; George J; Gonçalves PH; Marshall VA; Whitby D; Wang HW; Pittaluga S; Jaffe ES; Little RF; Uldrick TS; Yarchoan R
Blood Adv; 2021 Mar; 5(6):1660-1670. PubMed ID: 33720337
[TBL] [Abstract][Full Text] [Related]
12. [Favorable outcome of Castleman's disease treated with oral valganciclovir].
Valencia ME; Moreno V; Martínez P; Casado I
Med Clin (Barc); 2005 Sep; 125(10):399. PubMed ID: 16185555
[No Abstract] [Full Text] [Related]
13. New approaches to the treatment of human herpesvirus 8-associated disease.
Casper C
Rev Med Virol; 2008; 18(5):321-9. PubMed ID: 18615774
[TBL] [Abstract][Full Text] [Related]
14. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
15. HIV-associated multicentric Castleman disease.
Oksenhendler E
Curr Opin HIV AIDS; 2009 Jan; 4(1):16-21. PubMed ID: 19343828
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.
Krown SE; Dittmer DP; Cesarman E
J Infect Dis; 2011 Apr; 203(8):1082-6. PubMed ID: 21450998
[TBL] [Abstract][Full Text] [Related]
18. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.
Casper C; Krantz EM; Corey L; Kuntz SR; Wang J; Selke S; Hamilton S; Huang ML; Wald A
J Infect Dis; 2008 Jul; 198(1):23-30. PubMed ID: 18491970
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
[TBL] [Abstract][Full Text] [Related]
20. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.
Casper C; Nichols WG; Huang ML; Corey L; Wald A
Blood; 2004 Mar; 103(5):1632-4. PubMed ID: 14615380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
